We have investigated whether improvements in design have altered the outcome for patients undergoing endoprosthetic replacement of the proximal tibia following resection of a tumour. Survival of the implant and 'servicing' procedures have been documented using a prospective database.
We have investigated whether improvements in design have altered the outcome for patients undergoing endoprosthetic replacement of the proximal tibia following resection of a tumour. Survival of the implant and 'servicing' procedures have been documented using a prospective database.
A total of 194 patients underwent a proximal tibial replacement, with 95 having a fixedhinge design and 99 a rotating-hinge with a hydroxyapatite collar; their median age was 21.5 years (10 to 74). At a mean follow-up of 14.7 years (5 to 29), 115 patients remain alive. The risk of revision for any reason in the fixed-hinge group was 32% at five years, 61% at ten years and 75% at 15 and 20 years, and in the rotating-hinge group 12% at five years, 25% at ten years and 30% at 15 years. Aseptic loosening was the most common reason for revision in the fixed-hinge knees, fracture of the implant in the early design of rotating hinges and infection in the current version. The risk of revision for aseptic loosening in the fixed-hinge knees was 46% at ten years. This was reduced to 3% in the rotating-hinge knee with a hydroxyapatite collar. The cemented, rotating hinge design currently offers the best chance of long-term survival of the prosthesis.
The proximal tibia is the second most common site for primary malignant bone tumours. In the past 30 years, limb salvage, made possible by improvements in imaging, chemotherapy, surgical technique and biomechanical engineering has replaced amputation as the mainstay of surgical treatment. [1] [2] [3] [4] [5] The techniques for limb salvage in the proximal tibia include endoprosthetic replacement with either a custom-built or modular endoprosthesis, 6, 7 replacement with an allograft 8, 9 or resection followed by arthrodesis. 10, 11 The main potential complications associated with endoprostheses are local recurrence, infection, aseptic loosening, mechanical failure and fracture of the prosthesis or bone. [12] [13] [14] No large studies comparing the outcomes in fixed and rotating hinge designs of proximal tibial replacement systems have been published previously. We describe our experience with endoprosthetic replacement of the proximal tibia over 30 years and compare the results following the conversion from a fixed-to a rotating-hinge design.
Patients and Methods
Between November 1977 and February 2002, 194 consecutive patients underwent resection of the proximal tibia and endoprosthetic replacement. There were also 38 children with an extendable endoprosthesis who were excluded from this series. During this period, a further 34 patients with upper tibial tumours underwent amputation, giving a primary amputation rate of 13% for tumours at this site.
The youngest patients in this series had not reached skeletal maturity and the endoprosthesis inserted was longer than the bone removed in an attempt to obtain equal leg-length at the completion of growth. Details of the tumour, treatment and the outcome were entered prospectively into a database. The operations were all carried out at a single institution (Royal Orthopaedic Hospital, Birmingham, United Kingdom) by the oncological surgical team. Adjuvant chemotherapy was administered where appropriate, at the patient's local oncology unit according to contemporary nationally-agreed protocols.
All of the prostheses were custom made, and most were designed and manufactured at the Department of Biomedical Engineering of the Institute of Orthopaedics of University College, London (now known as Stanmore Implants Worldwide, Royal National Orthopaedic Hospital Trust, Stanmore, Middlesex).
Oncology
A Stanmore type-knee with a restrained hinge and a central axis allowing flexion around the polyethylene bushes was used until 1991. After this, a design with a rotating hinge was used in an attempt to absorb rotational stresses and reduce wear on the bushes. The initial prostheses had a small pin which inserted inside the tibial tray to provide stability, but this was found to be prone to fracture. The tibial component was redesigned in 1996 to be much stronger. The bushes in the femoral component were made of ultrahigh molecular weight polyethylene (UHMWPE). Since 1988, all of the implants have been nitrided to harden the surface, in an attempt to reduce debris from metal wear, as the early implants produced notable metallosis of the surrounding tissues (Fig. 1) . Since 1992, all of the tibial components have had a hydroxyapatite (HA) collar at the bone/ prosthesis interface to encourage ingrowth of bone into the collar and decrease the risk of loosening.
All the operations were performed in a clean-air theatre. Antibiotic prophylaxis was given at the time of surgery and for up to 24 hours afterwards. Resection of the tumour was carried out following oncological principles, endeavouring to achieve a wide margin of resection, as defined by Enneking, Spanier and Goodman. 15 16 Following surgery, patients were mobilised with partial weight-bearing, progressing to full weight-bearing by the time of discharge at two weeks. Flexion to 45˚ was permitted during the first week. Six weeks after surgery, all patients returned to the hospital for a period of intensive inpatient physiotherapy. Patients were followed up every three months for two years, then every six months until five years after operation and annually thereafter. Outcome analysis. In 1993, Unwin, Cobb and Walker 17 classified failure as 'biological', resulting from infection, 'biomechanical', by loosening and fracture of the bone, or 'mechanical' because of breakage of the prosthesis or the need for a servicing procedure such as rebushing. The definition of 'failure' varies in different series and short-term results may underestimate rates of failure. We have considered failure under the categories which we have used previously in assessing endoprosthetic replacement of the distal femur. 18 These include: 1) the need for any further operation, whatever the cause; 2) the need for any revision of the prosthesis or part of the prosthesis because of failure of the implant resulting from aseptic loosening, breakage, infection, etc; 3) the incidence of failure of limb salvage because of amputation; and 4) the risk of the two main complications, namely aseptic loosening and infection.
We have used Kaplan-Meier 19 survival curves to assess the rates of failure using the time in years to the measured event (e.g. revision) from the date of the original surgery. Patients were censored for statistical analysis if the event to be measured had not occurred at the time they were last assessed or if an alternative event, such as amputation, had made them no longer susceptible to that risk. The results relating to age and follow-up have been presented as median values with interquartile ranges (IQR) rather than means, because of the skewed age distribution of the patients, since the conditions treated occur typically in young patients.
Survival of the prosthesis was taken from the day of implantation. Differences between groups were analysed using the chi-squared test for discrete variables and the two sample t -test or Mann-Whitney test for continuous variables. Survival analysis was done using the KaplanMeier survivorship with differences between groups identified using the log rank test. A p-value < 0.05 was considered to be significant. Photograph showing changes in the design of the prosthesis over time. The original Stanmore fixed-hinge prosthesis (left) (Stanmore Implants Worldwide, Stanmore, United Kingdom) was replaced by a rotating hinge with a hydroxyapatite collar at the bone prosthesis interface on the tibia to encourage bony in-growth and improve long-term fixation (right). There is also an improved patellofemoral articulation.
Results
Between November 1977 and February 2002, 194 patients had endoprosthetic replacement of the proximal tibia. There were 118 males and 76 females, aged between ten and 74 years, with a median of 21.5 years (IQR, 17 to 36) (Fig. 2) . The different diagnoses treated are listed in Table I . The majority of the patients were treated for primary bone tumours; osteosarcoma (105 patients) was the most common, followed by Ewing's sarcoma (18 patients) and chondrosarcoma (16 patients) . At the time of review 115 patients (59%) remain alive, with a mean follow-up of 14.7 years (IQR: 10.5 to 19, range: 5 to 29). Prior to 1991, 95 fixed-hinge endoprostheses were inserted. Since then, 99 rotating-hinge endoprostheses have been used. A revision procedure has been required in 54 patients (28%).
The survivorship of the prostheses at 5, 10, 15 and 20 years are summarised in Table II as failure through amputation, failure from infection, revision for implant failure including aseptic loosening and infection, any further surgery, and aseptic loosening.
Amputation was carried out on 34 patients (17.5%), 25 within the first five years after implantation of the endoprosthesis. The most common reasons for amputation were infection in 23 patients (11.8%) and local recurrence in ten (5.1%). One amputation was carried out for functional reasons. The early experience with endoprosthetic replacement of the proximal tibia was hampered by problems incurred following disruption of the extensor mechanism and difficulty in obtaining adequate reconstruction of the soft tissue. The use of gastrocnemius flaps has had a significant impact on the success of the procedure. Before flaps were used the risk of amputation at five and ten years following surgery was 26% and 28% respectively. Since the introduction of flaps, this has fallen to 11% and 14% respectively.
A total of 38 patients (19.5%) developed a deep infection of their primary prosthesis at a median of nine months (IQR 2 to 22). Of these, 16 required early amputation; 15 had revisions in two stages in an attempt to control the infection, of which 11 (73%) were successful, but four failed (27%), requiring amputation. The remaining patients have either died as a result of metastatic disease, have been treated with antibiotic suppression or are awaiting revision. Since the introduction of gastrocnemius flaps as part of the reconstruction, there has been a significant reduction in the incidence of infection, with 19 of 61 patients (31%) without a gastrocnemius flap having infection compared with 19 of 133 (14%) since the routine use of flaps (chi-squared test, p = 0.0136).
Fracture of the implants occurred in three fixed hinges and in seven of the rotating design. The early version of this latter prosthesis had a relatively weak rotating hinge component and seven of the 51 patients (14%) with this type of implant suffered a fracture and required a revision. The mean time to fracture was five years (0.75 to 8). There have been no fractures with the current design of rotating hinge which has been used since 1996 in 48 patients with a minimum follow-up of five years (maximum 11). Rebushing of the primary endoprosthesis was needed in 36 patients (20 fixed-hinge, 16 rotating-hinge), of which 16 required a second rebushing. The time from implantation to rebushing ranged between 3.7 and 17.7 years (median, 7.4; IQR, 4.9 to 9.5). The risk of rebushing in patients who had not undergone a previous revision was 10% at five years, 32% at ten years and 63% at 20 years, with no significant difference between the types of design of the prosthesis.
Of the 194 patients in the series, 54 (28%) have required revision of their implants. The introduction of gastrocnemius flaps was followed by the conversion to rotating-hinge prostheses. Analysis of revision rates comparing the fixedwith the rotating-hinge implant was carried out, taking into account the compounding variable of reconstruction with a gastrocnemius flap. This demonstrated that the main reason for improvement in the rates of revision was the introduction of the rotating-hinge design to supercede the fixed-hinge version. The improved survival was highly significant (log rank test, p < 0.0001) ( Table II) . The incidence of aseptic loosening fell from 46% to 3% at ten years (log rank test p < 0.0001) (Figs 3 and 4) . Aseptic loosening was the most common reason for revision in the fixed-hinge knees (22 patients) whilst fracture of the implant occurred in seven of the early design rotating hinges and infection in three of the current version. Since the problem with fractures of the tibial component has been resolved in the rotating-hinge prostheses, the risk of revision for any cause has decreased to 11% at five years and 18% at ten years.
Discussion
Simon et al 20 and Rougraff et al 21 have shown that while limb salvage is associated with a higher rate of local recurrence, there is no deterioration in overall survival. In com- Kaplan-Meier survival curve demonstrating the marked reduction in revision rates for aseptic loosening with the introduction of a rotatinghinge design (log rank test, p < 0.0001).
THE JOURNAL OF BONE AND JOINT SURGERY parison with amputation, limb salvage has been shown to be cost-effective, 22 with less decrease in the quality of life. 23, 24 Patients, in general, prefer limb salvage which has replaced amputation as the mainstay of treatment for primary bone tumours about the knee. It offers a considerable advantage in terms of function, appearance and psychological acceptance. 25 Endoprosthetic reconstruction following resection of a bone tumour of the proximal tibia creates a particular set of problems. The procedure necessarily sacrifices all the knee ligaments and thus a constrained or semi-constrained prosthesis is required. Constrained, fixed-hinge knee replacements have not fared well in patients with osteoarthritis. 26 A high rate of failure could therefore be expected following resection of a tumour which typically occurs in younger and physically active patients, placing high demands on the implants. The disruption of the extensor mechanism and significant muscle loss create further challenges in reconstruction. 27 Attempts have been made to address these. The high rates of infection have, in part, been improved by abandoning the use of synthetic grafts and using gastrocnemius flaps. Improvement in survival of the implants in endoprosthetic replacement of the distal femur has been demonstrated with conversion to a rotating hinge design. 18 However, the results for the distal femur cannot be extrapolated to the proximal tibia since there are clear differences in both functional outcomes and obstacles in reconstruction. 28 Early tibial replacements using the Stanmore fixed-hinge knee system had a high incidence of mechanical loosening. 12, 29 Since 1991 and the introduction of the Stanmore-SMILES rotating-hinge knee with an HA collar, our results show a significant improvement in survival of the implant in the proximal tibia. This may be a result of a number of factors including increased surgical experience, the use of techniques including the introduction of gastrocnemius flaps which have reduced the risk of infection and improvements in the design and fixation of the implants which have reduced the risk of mechanical failure and loosening.
Survival analysis with amputation as an end-point demonstrated an 18% risk of amputation at ten years. Of 34 amputations, ten were carried out for local recurrence of disease. Larger series have described amputation rates of between 12% and 15% 30, 31 at five years but there is a paucity of longer term data. The risk of a patient requiring an amputation will be related to the rate of local recurrence as well as infection. We have seen a declining trend in the incidence of local recurrence in that prior to 1991 the rate was 10.6%, falling to 4% after 1996. It can clearly be reduced by having a higher amputation rate initially, particularly for patients with large tumours in whom a marginal excision only can be achieved, but, certainly for osteosarcoma, this has not been shown to lead to improved overall survival. 32 There must be a careful assessment of the risks and benefits of limb salvage compared with amputation in situations like this.
The problem of infection following these procedures is related to the difficulties in achieving adequate soft-tissue cover. 33, 34 The median time to infection in our series was nine months. Infection remains a problem in orthopaedic oncology and methods of preventing it are being actively sought. 35 With increasing experience and the introduction of gastrocnemius flaps, we have seen a continuing decline in infection of the proximal tibial endoprostheses. Horowitz et al 36 found a high incidence of infection and loosening, with only one third of the prostheses in situ after eight years. Malawer and Chou 37 experienced infection in four of 13 tibial replacements, three of which required amputation.
In our patients, fracture of the prosthesis has accounted for a significant number of revisions, mostly with the early design of rotating-hinge implant, with only three occurring with the previous fixed-hinge design. We have not seen any fractures with the current version of the rotating hinge implant. Fractures have been seen in between 4% and 7% of the Kotz (Kotz Modular Tibia Femur Reconstruction system (Stryker Howmedica Osteonics, Rutherford, New Jersey) 30 and Modular Segmental Replacement System (Stryker, Newbury, United Kingdom). 38 Higher rates of up to 15% have been observed in studies which have considered distal femoral and proximal tibial replacement as a single series. 39 The survival analysis of the implant does not take into account all procedures which patients might undergo. The polyethylene bushings allow for a staged mechanism of failure, wearing out before mechanical failure or loosening of the implant itself. One or more rebushings of the primary implant were required in 36 patients (18.5%) and the longer the prosthesis is in situ the greater the risk that a rebushing will be required. The need for rebushing has not been eradicated by the introduction of the rotating-hinge implant and patients should be warned of the potential need for such procedures. Although technically simple, it still carries the risk of introducing infection around the prosthesis.
The results of this study show that of the 194 patients, 54 (28%) had required revision of their prosthesis. Since the rate of revision is much higher with the passage of time, it is essential that it should be reported as a Kaplan-Meier survival. Analysis of the existing literature on revision rates is complicated since some of the series report both proximal tibial and distal femoral replacements as a single category, while others do not differentiate between the different implants used. 31, 32, 34, 38, 40 However, overall, fixed-hinge proximal tibial replacements have a ten-year survival of approximately 40% with that of the rotating hinge being between 52% and 74%. 31, 32, 34, 38, 40 We have shown that failures resulting from both infection and local recurrence have improved with time. Hydroxyapatite provides effective bio-active supplementary fixation of implants to bone, 41, 42 and aseptic loosening appears to have been greatly reduced by the introduction of a rotating-hinge knee in combination with the implant host interface provided by the HA collar. Improvements in surgical technique and soft-tissue reconstruction, in combination with advances in implant design and bone integration, have resulted in the considerable enhancement of the chances of long-term survival of the implant following resection and endoprosthetic replacement of tumours of the proximal tibia.
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